Rheopheresis as Adjuvant Treatment of Calciphylaxis
Condition(s):Metabolic Disorder; End Stage Renal Disease; Rare DiseasesLast Updated:February 16, 2023Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Metabolic Disorder; End Stage Renal Disease; Rare DiseasesLast Updated:February 16, 2023Enrolling by invitation
Condition(s):Covid19; Systemic Autoimmune Disease; Inflammatory Rheumatism; Auto Inflammatory DiseasesLast Updated:January 13, 2023Terminated
Condition(s):Endocrine TumorLast Updated:August 8, 2023Recruiting
Condition(s):Hyperammonemia; Methylmalonic Acidemia; Propionic AcidemiaLast Updated:January 30, 2024Recruiting
Condition(s):Duchenne Muscular DystrophyLast Updated:September 1, 2022Active, not recruiting
Condition(s):Rare Diseases; Fabry Disease; Adherence, Medication; Quality of LifeLast Updated:July 11, 2022Recruiting
Condition(s):Inherited Epidermolysis Bullosa; Ichthyosis; Ectodermal Dysplasia; Incontinentia Pigmenti; Neurofibromatosis Type 1; Albinism; Pemphigus; Mucous Membrane Pemphigoid; Palmoplantar KeratodermaLast Updated:July 20, 2023Recruiting
Condition(s):Parkinson DiseaseLast Updated:March 17, 2023Not yet recruiting
Condition(s):Epilepsy; Seizure Disorder; Neurologic Disorder; Rare DiseasesLast Updated:February 20, 2024Recruiting
Condition(s):Myelodysplastic SyndromeLast Updated:June 2, 2009Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.